Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1000 participants.

Also called NCT06801457

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06801457
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06801457. Randomized; single masking; primary purpose treatment. Start 2025-02-01 (anticipated); primary completion 2028-01-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke
Acronym
AN-O2-EMS
Condition
Stroke Acute
Intervention (Other)
NBO
Intervention (Other)
Control
Lead sponsor
Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct06801457
Content hash
13828b3e68a83e33c011e85f46717d727159f56fbffc4642c390ced4e27cda0c